Testing effectiveness (Phase 2)UnknownNCT03638375What this trial is testingTIL and Anti-PD1 in Metastatic MelanomaWho this might be right forToxicity, DrugAdverse Drug EventEffects of Immunotherapy Leiden University 34
Not applicableUnknownNCT04595734What this trial is testingLiver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.Who this might be right forLung Cancer Stage IVLung Cancer, Non-small CellHepatitis Western Sydney Local Health District 500
Not applicableUnknownNCT05564923What this trial is testingCARG, VES13, G8 Scales in Predicting Drug Toxicity in Patients Receiving NivolumabWho this might be right forNivolumab Related Toxicity Namik Kemal University 100
Not applicableLooking for participantsNCT05652673What this trial is testingSafe Stop Ipilimumab-nivolumab (IPI-NIVO) TrialWho this might be right forMelanoma Stage IVMelanoma Stage IIIImmunotherapy+1 more Erasmus Medical Center 80
Not applicableStudy completedNCT06440811What this trial is testingEfficacy and Safety of Neoadjuvant Nivolumab Plus SOX Versus Nivolumab Plus FLOT in Patients With HER2-negative Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forImmune-related Adverse EventChemotherapeutic ToxicityGastric or Gastroesophageal Junction Adenocarcinoma Xijing Hospital 120